The growth-investment cockpit — the real ₹2,044 Cr FY26 program (Egypt aseptic, Dharwad BOPP, Noida recycling, Mexico WPP & CPP, Sanand, Panipat, Egypt chips) scored, sequenced and proven against ROI.
The ₹2,044 Cr FY26 capex program is committed and pricing at 7.8x incremental EBITDA with 2.1x average ROI — but it took leverage to 4.35×, so the job now is conversion, not commitment. Commission Egypt aseptic (the one IOI, ₹850 Cr), ramp the 3 commissioned lines (₹1,080 Cr), and hold FY27 capex to ~₹1,400 Cr so volumes deleverage the balance sheet.
2 of 4 headline metrics improving vs prior · still off target: Net Debt / EBITDA 4.3x vs 3.0x, Covenant Headroom 1.1x vs 2.5x, Program Realization (Mix / Circularity / WC) 68.0% vs 100.0%
Egypt aseptic (IOI, USD 95.7 of 126 mn spent) gates FY27 aseptic growth; the 3 commissioned LOI lines (Sanand, Panipat, Mexico CPP) must ramp to nameplate — commissioned-but-idle capex is pure leverage.
Natural-hedge via exports, review CIS repatriation quarterly, disclose devaluation sensitivity (FY25 took ₹178 Cr exceptional).
USD/INR averaged 85.4 (Q1) → 91.7 (Q4), closing 94.65; Russia/CIS plant (48 kTPA) operating; West Asia conflict freight risk.
Track commissioning milestones monthly — FY27 volume-led growth is the deleverage plan's engine.
Egypt aseptic (USD 126 mn) near commissioning; Dharwad BOPP ₹715 Cr FY28; Mexico WPP in validation; CWIP ₹2,169 Cr.
Thin headroom caps FY27 capex & refinancing latitude — deleverage is the plan, not yet the achievement.
This is the capex cockpit — sourcing → diligence → capex → execution-risk on all 8 live initiatives, paired with the proof that past capex returned. The honest frame: this cycle took leverage to 4.35×, so headroom (₹2,282 Cr to the modeled 5.5× ceiling) is a guardrail, not a budget — FY27 is about commissioning and ramping, with capex moderating toward ₹1,400 Cr.
Stage ladder: Sourced → Contacted → Diligence → IOI (near commissioning) → LOI (commissioned & selling). 8 of 8 initiatives price inside the ₹2,282 Cr of ceiling headroom.
Move: 3 lines are commissioned (LOI — Sanand aseptic, Panipat chips, Mexico CPP, ₹1,080 Cr incremental revenue at ramp) and Egypt aseptic sits at IOI (₹850 Cr) awaiting final validation. The near-term prize is ramp, not new commits; Dharwad BOPP (1 Sourced, FY28) is the next gate decision.
Every initiative, LOI first. Read value-add mix up, customer concentration and execution-risk down — those gate the capex.
| Initiative | Division · Location | Incr. revenue | EBITDA % | Stage | Capex × | Capex | ROI target | Value-add % | Cust conc % | Exec risk | Owner | Status detail |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanand aseptic brownfield (7→12 bn packs) Brownfield expansion commissioned during FY26 — Sanand now 12 bn packs/yr. | Flexible Packaging, Aseptic & Holography · India | ₹550 Cr | 18% | LOI | 4.04x | ₹400 Cr | 2.5x | 85% | 28% | 20 | President — Aseptic Liquid Packaging (Asepto) | DONE (FY26) — capacity live; 7.97 bn packs sold |
Panipat vPET chips bottle-grade upgrade (168 kTPA) 100% bottle-grade capability; ~65% of volume sold third-party — backward integration + a chips trading book. | Packaging Films (incl. PET chips) · India | ₹320 Cr | 9% | LOI | 5.21x | ₹150 Cr | 2x | 30% | 35% | 15 | P.L. Sirsamkar | DONE — operational since Apr 2024, upgraded FY26 |
Mexico CPP line (18 kTPA) New CPP capacity at Altamira — first full year in FY26; feeds North-America converting demand. | Packaging Films (incl. PET chips) · Americas | ₹210 Cr | 13% | LOI | 8.42x | ₹230 Cr | 2.1x | 35% | 26% | 18 | Anantshree Chaturvedi | DONE (FY26) — commissioned & selling |
Egypt aseptic greenfield (12 bn packs) USD 126 mn greenfield doubling aseptic capacity to 24 bn packs — targets Egypt / Europe / Middle East / East Africa. | Flexible Packaging, Aseptic & Holography · Middle East & Africa | ₹850 Cr | 18% | IOI | 7.78x | ₹1,190 Cr | 2.2x | 80% | 25% | 45 | President — Aseptic Liquid Packaging (Asepto) | USD 95.7 mn spent by Mar-26; near commissioning (FY27) |
Egypt film-grade chips ramp (216 kTPA) Film-grade PET chips feeding the Egypt films hub — commissioned end-FY25, ramping (72.3% util Q4). | Packaging Films (incl. PET chips) · Middle East & Africa | ₹700 Cr | 11% | Diligence | 8.83x | ₹680 Cr | 1.9x | 25% | 20% | 30 | Anantshree Chaturvedi | Ramping to nameplate through FY27 |
Noida recycling plant (36 kTPA rPET + 3.6 kTPA MLP) India-first PCR washing-recycling plant (Sector 155) — EPR recycled-content mandates are the demand tailwind. | Packaging Films (incl. PET chips) · India | ₹300 Cr | 14% | Diligence | 5.95x | ₹250 Cr | 2.4x | 60% | 22% | 35 | Head of Recycling & Circularity (Project Plastic Fix) | Commissioned early FY27; ramping offtake |
Mexico WPP pet-food bags (80 mn bags/yr) Woven-PP pet-food bag plant at Altamira (~USD 52 mn spent) — Americas pet-food adjacency. | Packaging Films (incl. PET chips) · Americas | ₹260 Cr | 16% | Contacted | 11.78x | ₹490 Cr | 1.9x | 55% | 30% | 50 | Anantshree Chaturvedi | In validation; commercial ramp FY27 |
Dharwad BOPP line (54 kTPA) ₹715 Cr BOPP line — south-India films capacity for FY28; the next films leg. | Packaging Films (incl. PET chips) · India | ₹590 Cr | 12% | Sourced | 10.1x | ₹715 Cr | 1.8x | 20% | 18% | 40 | P.L. Sirsamkar | Under construction; commissioning FY2027-28 |
Easiest to execute first. Clean, value-added builds go now; concentrated, complex initiatives get hard diligence and an off-take gate.
Execution priority: commission the top of this list first — low risk plus high value-added mix banks the run-rate fast and keeps the PMO unblocked before the heavier, concentration-risk initiatives enter the build plan.
Avg implied ROI 2.1x across the 8 initiatives; 73% of program capture banked. Lagging: none.
| Initiative | Started | Capex | Capex × | EBITDA plan | EBITDA real | Implied ROI | Payback | IRR % |
|---|---|---|---|---|---|---|---|---|
| Dharwad BOPP line (54 kTPA) | 2027 | ₹715 Cr | 10.1x | ₹71 Cr | ₹0 Cr | 1.8x | 8y | 12% |
| Egypt aseptic greenfield (12 bn packs) | 2026 | ₹1,190 Cr | 7.8x | ₹153 Cr | ₹12 Cr | 2.2x | 6.5y | 16% |
| Noida recycling plant (36 kTPA rPET + 3.6 kTPA MLP) | 2026 | ₹250 Cr | 6x | ₹42 Cr | ₹8 Cr | 2.4x | 5.4y | 18% |
| Mexico WPP pet-food bags (80 mn bags/yr) | 2026 | ₹490 Cr | 11.8x | ₹42 Cr | ₹4 Cr | 1.9x | 7.6y | 13% |
| Mexico CPP line (18 kTPA) | 2026 | ₹230 Cr | 8.4x | ₹27 Cr | ₹14 Cr | 2.1x | 6y | 15% |
| Sanand aseptic brownfield (7→12 bn packs) | 2025 | ₹400 Cr | 4x | ₹99 Cr | ₹48 Cr | 2.5x | 4y | 22% |
| Egypt film-grade chips ramp (216 kTPA) | 2025 | ₹680 Cr | 8.8x | ₹77 Cr | ₹38 Cr | 1.9x | 6.8y | 14% |
| Panipat vPET chips bottle-grade upgrade (168 kTPA) | 2024 | ₹150 Cr | 5.2x | ₹29 Cr | ₹22 Cr | 2x | 5.2y | 17% |
Read: the highest-return programs (Sanand aseptic brownfield at 2.5x / 4-year payback, Noida recycling at 2.4x on the EPR tailwind) prove the model works when the ramp lands. No initiative sits below 1.3x target ROI — but the biggest tickets (Egypt aseptic USD 126 mn and Dharwad BOPP ₹715 Cr, zero EBITDA today) still depend entirely on the ramp landing; every quarter of commissioning slip is a quarter of leverage at 4.35×.
Listed films & packaging peers (and the aseptic incumbents Tetra Pak / SIG) set the competitive bar for every rupee of our capex.
| Date | Peer | Move | Value | End-market | Read-through |
|---|---|---|---|---|---|
| 2026-05-28 | Polyplex Corp | Pure-films peer — FY26 ₹7,086 Cr revenue at 4.9% OPM | ₹3,480 Cr | Packaging films | Commodity-spread pressure mirrors UFlex films; UFlex's converting mix is the differentiator. |
| 2026-05-15 | EPL Ltd | Margin-quality benchmark — 20% OPM laminated tubes | ₹7,264 Cr | Packaging (tubes) | EPL's ₹7,264 Cr mcap is 2× UFlex's on ⅓ the revenue — the margin-quality gap IS the re-rating case. |
| 2026-04-30 | Cosmo First | Specialty & BOPP mix shift (11% OPM) | ₹2,339 Cr | Packaging films | Specialty-mix strategy benchmark on a smaller base (₹3,639 Cr revenue). |
| 2026-03-20 | Tetra Pak / SIG | Aseptic capacity & India push | ₹1,200 Cr | Aseptic | Asepto's real rivals — Egypt greenfield contests MEA before they lock it. |
| 2026-02-10 | SRF (Packaging Films) | BOPP & aluminium-foil capacity additions | ₹5,600 Cr | Packaging films | Chemicals-led parent; packaging-films segment ~₹5.5-5.7k Cr (estimate) keeps India capacity contested. |
| 2026-01-18 | Jindal Poly Films | BOPET/BOPP debottlenecking | ₹2,774 Cr | Packaging films | FY26 profit flattered by fair-value gains; watch real spreads, not headlines. |
So what: SRF, Jindal, Polyplex and Cosmo keep India films capacity contested (the ~260 KT BOPET glut), while EPL shows what margin quality is worth — 2× UFlex's mcap on ⅓ the revenue. Hold capex discipline near our 7.8x average and lead with aseptic, recycling and value-added programs, where the ROI and the re-rating case are strongest — and where Tetra Pak / SIG will contest MEA if Egypt slips.